Oral small-molecule GLP-1 RA improves blood glucose and weight reduction

GLP-1 Therapy Reduces Migraine Frequency by More Than Half in Obesity Patients

A study from the University of Naples found that liraglutide, a GLP-1 receptor agonist typically used for diabetes and obesity, significantl

Two Observational Studies Link GLP-1 Receptor Agonists to Reduced Breast Cancer Risk in Women with Obesity

Two observational studies found that GLP-1 receptor agonists (like Ozempic, Wegovy) are associated with reduced breast cancer incidence in w

GLP-1 Drugs Linked to 30% Lower Breast Cancer Risk in New Study

New research published in the Journal of Clinical Oncology suggests GLP-1 weight loss medications may reduce cancer risk. An observational s

Effects of GLP-1RAs on Fertility Outcomes in Obese Women With PCOS

Triple hormone drug retatrutide shows promise for diabetes and weight loss in Lancet trial

A new triple hormone drug called retatrutide, which mimics GLP-1, GIP, and glucagon, has shown promising results in a Lancet-published trial

GLP-1 Receptor Agonists Linked to Small Risk of Smell and Taste Disturbances in Type 2 Diabetes

A study published in JAMA Otolaryngology-Head & Neck Surgery found that GLP-1 receptor agonists (RAs) used for type 2 diabetes are associate